Decreased [99mTc]Sestamibi uptake with dobutamine versus dipyridamole stress

R. Sciagrà, O. Zoccarato, G. Bisi, A. Pupi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim. Animal studies suggest an interference of dobutamine on [ 99mTc]sestamibi uptake. In this study dobutamine was compared to dipyridamole rest-stress [99mTc]sestamibi uptake ratio (UR). Methods. Twenty-five patients with suspect coronary artery disease (CAD) underwent rest, dobutamine, and dipyridamole [99mTc]sestamibi SPECT at 24-h intervals and coronary angiography. UR was calculated separately for each coronary territory considering injected dose and acquisition delay. Results. There were 38 CAD territories in 20 patients. On a patient basis, dipyridamole SPECT sensitivity was 85%, versus 70% for dobutamine. On a territory basis, sensitivity was 66% versus 42% (P99mTc]sestamibi uptake underestimates the blood flow heterogeneity induced by dobutamine more than that produced by dipyridamole.

Original languageEnglish
Pages (from-to)671-677
Number of pages7
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume53
Issue number6
Publication statusPublished - Dec 2009

Fingerprint

Technetium Tc 99m Sestamibi
Dobutamine
Dipyridamole
Single-Photon Emission-Computed Tomography
Coronary Artery Disease
Coronary Angiography

Keywords

  • Coronary artery disease
  • Dipyridamole
  • Dobutamine

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Decreased [99mTc]Sestamibi uptake with dobutamine versus dipyridamole stress. / Sciagrà, R.; Zoccarato, O.; Bisi, G.; Pupi, A.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 53, No. 6, 12.2009, p. 671-677.

Research output: Contribution to journalArticle

@article{1407534690434c91933d5ccdd11f9afb,
title = "Decreased [99mTc]Sestamibi uptake with dobutamine versus dipyridamole stress",
abstract = "Aim. Animal studies suggest an interference of dobutamine on [ 99mTc]sestamibi uptake. In this study dobutamine was compared to dipyridamole rest-stress [99mTc]sestamibi uptake ratio (UR). Methods. Twenty-five patients with suspect coronary artery disease (CAD) underwent rest, dobutamine, and dipyridamole [99mTc]sestamibi SPECT at 24-h intervals and coronary angiography. UR was calculated separately for each coronary territory considering injected dose and acquisition delay. Results. There were 38 CAD territories in 20 patients. On a patient basis, dipyridamole SPECT sensitivity was 85{\%}, versus 70{\%} for dobutamine. On a territory basis, sensitivity was 66{\%} versus 42{\%} (P99mTc]sestamibi uptake underestimates the blood flow heterogeneity induced by dobutamine more than that produced by dipyridamole.",
keywords = "Coronary artery disease, Dipyridamole, Dobutamine",
author = "R. Sciagr{\`a} and O. Zoccarato and G. Bisi and A. Pupi",
year = "2009",
month = "12",
language = "English",
volume = "53",
pages = "671--677",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Decreased [99mTc]Sestamibi uptake with dobutamine versus dipyridamole stress

AU - Sciagrà, R.

AU - Zoccarato, O.

AU - Bisi, G.

AU - Pupi, A.

PY - 2009/12

Y1 - 2009/12

N2 - Aim. Animal studies suggest an interference of dobutamine on [ 99mTc]sestamibi uptake. In this study dobutamine was compared to dipyridamole rest-stress [99mTc]sestamibi uptake ratio (UR). Methods. Twenty-five patients with suspect coronary artery disease (CAD) underwent rest, dobutamine, and dipyridamole [99mTc]sestamibi SPECT at 24-h intervals and coronary angiography. UR was calculated separately for each coronary territory considering injected dose and acquisition delay. Results. There were 38 CAD territories in 20 patients. On a patient basis, dipyridamole SPECT sensitivity was 85%, versus 70% for dobutamine. On a territory basis, sensitivity was 66% versus 42% (P99mTc]sestamibi uptake underestimates the blood flow heterogeneity induced by dobutamine more than that produced by dipyridamole.

AB - Aim. Animal studies suggest an interference of dobutamine on [ 99mTc]sestamibi uptake. In this study dobutamine was compared to dipyridamole rest-stress [99mTc]sestamibi uptake ratio (UR). Methods. Twenty-five patients with suspect coronary artery disease (CAD) underwent rest, dobutamine, and dipyridamole [99mTc]sestamibi SPECT at 24-h intervals and coronary angiography. UR was calculated separately for each coronary territory considering injected dose and acquisition delay. Results. There were 38 CAD territories in 20 patients. On a patient basis, dipyridamole SPECT sensitivity was 85%, versus 70% for dobutamine. On a territory basis, sensitivity was 66% versus 42% (P99mTc]sestamibi uptake underestimates the blood flow heterogeneity induced by dobutamine more than that produced by dipyridamole.

KW - Coronary artery disease

KW - Dipyridamole

KW - Dobutamine

UR - http://www.scopus.com/inward/record.url?scp=77949819505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949819505&partnerID=8YFLogxK

M3 - Article

C2 - 20016457

AN - SCOPUS:77949819505

VL - 53

SP - 671

EP - 677

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 6

ER -